Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.15
+0.01 (0.19%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Third Harmonic Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Third Harmonic Bio stock have an average target of 5.00, which predicts a decrease of -2.91% from the current stock price of 5.15.
Analyst Consensus: Hold
* Price targets were last updated on Mar 28, 2025.
Analyst Ratings
The average analyst rating for Third Harmonic Bio stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy → Hold Downgrades $23 → $5 | Strong Buy → Hold | Downgrades | $23 → $5 | -2.91% | Mar 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $20 → $5 | Buy → Hold | Downgrades | $20 → $5 | -2.91% | Feb 12, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $12 → $20 | Hold → Buy | Upgrades | $12 → $20 | +288.35% | Aug 9, 2024 |
| Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +346.60% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.01
from -1.09
EPS Next Year
-1.11
from -1.01
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.89 | -0.92 | -0.84 | ||
| Avg | -1.01 | -1.11 | -1.08 | ||
| Low | -1.19 | -1.48 | -1.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.